title: HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral action.
authors.affiliation: School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia; Centre for Cancer Biology, Adelaide, Australia.
authors.forename: Nicholas S
authors.initials: NS
authors.lastname: Eyre
authors.affiliation: School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia; Centre for Cancer Biology, Adelaide, Australia. Electronic address: michael.beard@adelaide.edu.au.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Beard
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D002219:Carbamates; D002462:Cell Membrane / Q000187:drug effects*; D016174:Hepacivirus / Q000187:drug effects*; D022781:Hepatocytes / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D011759:Pyrrolidines; D014633:Valine / Q000031:analogs & derivatives; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*; D014779:Virus Replication / Q000187:drug effects*; D012324:RNA-Dependent RNA Polymerase
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D011480:Protease Inhibitors; D011759:Pyrrolidines; D014633:Valine; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase; C549273:daclatasvir